It’s just one of the sessions not to miss at this year’s ESC Congress, being held 25-29 August in Munich, Germany.
The Congress kicks off on Saturday 25 August, with a fuller scientific programme than ever. For the first time there is a full press programme on Saturday with three press conferences.
The press conference schedule is packed with the latest science and great news stories. Long awaited results of clinical trials such as ALTITUDE, FAME II, FAST MI, PROTECT, De FACTO, WOEST and TRILOGY ACS will be announced. Other groundbreaking content has been grouped under eight themed headings. New techniques such as Renal Denervation will be among the spotlights of our press conferences: come and hear about how zapping overactive kidney nerves can lower blood pressure in patients who don’t respond to drugs. And how politicians can influence lifestyle changes to prevent cardiovascular disease.
Professor Michael Böhm, Chairperson of the ESC Congress Programme Committee, said: “The ESC Congress is the top international cardiovascular event of the year and 2012 has more new science than ever. Hold the front page for results presented in Hot Line sessions. These are some of the most exciting sessions in the cardiovascular calendar and will influence future treatment of heart disease.”
Online registration is now closed, but dedicated desks for Press Registration will be available on-site from the morning of Friday 24 August. For more information contact the ESC press office at press@escardio.org
This Phys.org Science News Wire page contains a press release issued by an organization mentioned above and is provided to you “as is” with little or no review from Phys.Org staff.
